Imuracetam

Imuracetam
Names
Preferred IUPAC name
N,N′-Bis[(2-oxopyrrolidin-1-yl)methyl]urea
Other names
UCB-G218
Identifiers
3D model (JSmol)
ChEMBL
ChemSpider
UNII
  • InChI=1S/C11H18N4O3/c16-9-3-1-5-14(9)7-12-11(18)13-8-15-6-2-4-10(15)17/h1-8H2,(H2,12,13,18) checkY
    Key: WMKONRFEZGAHTE-UHFFFAOYSA-N checkY
  • InChI=1/C11H18N4O3/c16-9-3-1-5-14(9)7-12-11(18)13-8-15-6-2-4-10(15)17/h1-8H2,(H2,12,13,18)
    Key: WMKONRFEZGAHTE-UHFFFAOYAT
  • O=C(NCN1C(=O)CCC1)NCN2C(=O)CCC2
Properties
C11H18N4O3
Molar mass 254.290 g·mol−1
Melting point 184.5 °C (364.1 °F; 457.6 K)[1]
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
checkY verify (what is checkY☒N ?)
Infobox references

Imuracetam (INNTooltip International Nonproprietary Name; developmental code name UCB-G218) is a drug of the racetam group described as a nootropic (cognitive enhancer).[2][3] It was under development in the 1970s but was never marketed.[1]

References

  1. ^ a b Ganellin CR, Triggle DJ (1996). Dictionary of Pharmacological Agents. Vol. 3. CRC Press.
  2. ^ Elks, J. (2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer US. p. 681. ISBN 978-1-4757-2085-3. Retrieved 1 October 2024.
  3. ^ Avetisyan SA, Kocharov SL, Azaryan LV, Dzhagatspanyan IA, Melikyan GG (February 1998). "Synthesis and psychotropic activity of new 2-pyrrolidone derivatives". Pharmaceutical Chemistry Journal. 32 (2): 55–58. doi:10.1007/BF02464161. S2CID 29810469.


This article is issued from Wikipedia. The text is available under Creative Commons Attribution-Share Alike 4.0 unless otherwise noted. Additional terms may apply for the media files.